Skip to main content

Table 1 Basic demographic data of patients with hepatocellular carcinoma of different BCLC stages

From: Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis

Variable Total (N = 2316) BCLC stage 0 (N = 66) BCLC stage A (N = 865) BCLC stage B (N = 575) BCLC stage C (N = 810)
Male 1748 (75.5) 46 (69.7) 605 (69.6) 437 (76.0) 660 (81.5)
Age (years) 63 (19–99) 62 (23–85) 63 (28–92) 64 (30–91) 61 (19–99)
Smoking 949 (41.0) 28 (42.4) 316 (36.5) 232 (40.3) 373 (46.0)
Alcohol use 868 (37.5) 22 (33.3) 283 (32.7) 218 (37.9) 345 (42.6)
HBV positive 1658 (71.6) 44 (66.7) 599 (69.2) 414 (72.0) 601 (74.2)
HCV positive 696 (30.1) 14 (21.2) 253 (29.2) 172 (29.9) 257 (31.7)
Cirrhosis 1395 (60.2) 43 (65.2) 511 (59.1) 334 (58.1) 507 (62.6)
Child–Pugh class A 877 (37.9) 66 (100) 277 (32.0) 225 (39.1) 309 (38.1)
Tumor size (cm) 6.1 (1.0–27) 1.7 (1.0–2.0) 2.9 (1.0–5.0) 7.5 (1.2–21) 9.4 (1.2–27)
Tumor number 2.1 (1–11) 1 (1–1) 1.5 (1–3) 2.5 (1–11) 2.7 (1–11)
Treatment,
surgery
538 (23.2) 27 (40.9) 289 (33.4) 164 (28.5) 58 (7.2)
Mortality 1302 (56.2) 37 (56.9) 472 (54.6) 313 (54.4) 480 (59.3)
Median follow-up duration (months) 20 (0–96) 52 (8–96) 32 (1–96) 19 (0–84) 12 (0–79)
  1. BCLC stage: Barcelona clinic liver cancer; HBV: Hepatitis B virus; HCV: Hepatitis C virus; OS: Overall survival; Number (%); Mean (range)